Professor Philip Mitchell


The risk of developing bipolar disorder has a correlation with weak connections in the emotional areas of the brain. 


For the first time scientists have identified genetic markers that can predict whether a patient will respond to bipolar disorder medication, providing new insight into how mood stabilising drugs work.


A new project to sequence the genomes of families living with bipolar disorder should identify some of the complex genetic factors behind the debilitating disease.

Five-hundred Australians are being sought by UNSW and the Black Dog Institute for a study to pinpoint the risk factors for developing bipolar disorder.